{"transactions":[{"id":726253,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-25T22:08:17.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":2324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."}],"balance_after":2324,"derivative":{"underlying":"Common Stock","underlying_shares":2324},"source":{"system":"sec-edgar","filing":"0001104659-26-077866","document":"tm2619022-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465926077866/tm2619022-4_4seq1.xml","form_type":"4"}},{"id":726252,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-25T22:08:17.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":3691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":3691,"derivative":{"exercise_price":107.55,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":3691},"source":{"system":"sec-edgar","filing":"0001104659-26-077866","document":"tm2619022-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465926077866/tm2619022-4_4seq1.xml","form_type":"4"}},{"id":726251,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-25T22:08:17.000Z","date":"2026-06-23","kind":"exercise","planned":false,"acquired":false,"shares":4712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units are fully vested. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units are fully vested. The restricted stock units have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4712},"source":{"system":"sec-edgar","filing":"0001104659-26-077866","document":"tm2619022-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465926077866/tm2619022-4_4seq1.xml","form_type":"4"}},{"id":726250,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-25T22:08:17.000Z","date":"2026-06-23","kind":"exercise","planned":false,"acquired":true,"shares":4712,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."}],"balance_after":11712,"source":{"system":"sec-edgar","filing":"0001104659-26-077866","document":"tm2619022-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465926077866/tm2619022-4_4seq1.xml","form_type":"4"}},{"id":910402,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-11T21:43:08.000Z","date":"2026-02-09","kind":"gift","planned":false,"acquired":true,"shares":53400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By family trust"},"balance_after":53400,"source":{"system":"sec-edgar","filing":"0001219023-26-000002","document":"wk-form4_1770846185.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000121902326000002/wk-form4_1770846185.xml","form_type":"4"}},{"id":910401,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-11T21:43:08.000Z","date":"2026-02-09","kind":"gift","planned":false,"acquired":false,"shares":53400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":44323,"source":{"system":"sec-edgar","filing":"0001219023-26-000002","document":"wk-form4_1770846185.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000121902326000002/wk-form4_1770846185.xml","form_type":"4"}},{"id":1100920,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-26T20:30:46.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":4712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."}],"balance_after":4712,"derivative":{"underlying":"Common Stock","underlying_shares":4712},"source":{"system":"sec-edgar","filing":"0001104659-25-063064","document":"tm2519230-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465925063064/tm2519230-1_4seq1.xml","form_type":"4"}},{"id":1100919,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-26T20:30:46.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":7037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":7037,"derivative":{"exercise_price":63.66,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":7037},"source":{"system":"sec-edgar","filing":"0001104659-25-063064","document":"tm2519230-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465925063064/tm2519230-1_4seq1.xml","form_type":"4"}},{"id":1103563,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-23T20:49:41.000Z","date":"2025-06-18","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units fully vested on June 18, 2025. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units fully vested on June 18, 2025. The restricted stock units have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001104659-25-061708","document":"tm2518591-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465925061708/tm2518591-2_4seq1.xml","form_type":"4"}},{"id":1103562,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-23T20:49:41.000Z","date":"2025-06-18","kind":"exercise","planned":false,"acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001104659-25-061708","document":"tm2518591-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465925061708/tm2518591-2_4seq1.xml","form_type":"4"}},{"id":1116129,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-10T20:28:20.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) granted to the Reporting Person as an annual award for service on the Board of Directors. The RSUs will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders, subject to continued board service through the applicable vesting date. The RSUs will vest in full upon the occurrence of a change in control of the Issuer."}],"balance_after":4722,"source":{"system":"sec-edgar","filing":"0001628280-25-030492","document":"wk-form4_1749587293.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000162828025030492/wk-form4_1749587293.xml","form_type":"4"}},{"id":1121047,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T20:16:42.000Z","date":"2025-06-03","kind":"exercise","planned":true,"acquired":false,"shares":65431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.59,"expiration_date":"2025-11-16","underlying":"Common Stock","underlying_shares":65431},"source":{"system":"sec-edgar","filing":"0001104659-25-056844","document":"tm2517215-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465925056844/tm2517215-2_4seq1.xml","form_type":"4"}},{"id":1121046,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:16:42.000Z","date":"2025-06-03","kind":"sale","planned":true,"acquired":false,"shares":9873,"price":65.6427,"value":648090.3771,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $65.59 to $65.81 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001104659-25-056844","document":"tm2517215-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465925056844/tm2517215-2_4seq1.xml","form_type":"4"}},{"id":1121045,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:16:42.000Z","date":"2025-06-03","kind":"sale","planned":true,"acquired":false,"shares":55558,"price":65.1464,"value":3619403.6912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $64.59 to $65.58 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":12873,"source":{"system":"sec-edgar","filing":"0001104659-25-056844","document":"tm2517215-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465925056844/tm2517215-2_4seq1.xml","form_type":"4"}},{"id":1121044,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:16:42.000Z","date":"2025-06-03","kind":"exercise","planned":true,"acquired":true,"shares":65431,"price":4.59,"value":300328.29,"ownership":{"direct":true},"balance_after":68431,"source":{"system":"sec-edgar","filing":"0001104659-25-056844","document":"tm2517215-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465925056844/tm2517215-2_4seq1.xml","form_type":"4"}},{"id":1123386,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T20:41:37.000Z","date":"2025-06-04","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":73.27,"value":219810.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This is the weighted average sales price representing 3,000 shares sold at prices ranging from $73.13 to $73.41 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request."}],"balance_after":97723,"source":{"system":"sec-edgar","filing":"0001628280-25-029370","document":"wk-form4_1749069680.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000162828025029370/wk-form4_1749069680.xml","form_type":"4"}},{"id":1123385,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T20:41:37.000Z","date":"2025-06-03","kind":"sale","planned":true,"acquired":false,"shares":3250,"price":71.3,"value":231725.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This is the weighted average sales price representing 3,250 shares sold at prices ranging from $71.09 to $71.54 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request."}],"balance_after":100723,"source":{"system":"sec-edgar","filing":"0001628280-25-029370","document":"wk-form4_1749069680.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000162828025029370/wk-form4_1749069680.xml","form_type":"4"}},{"id":1143489,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:56:58.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":5058,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU was granted on May 15, 2025 for no consideration."}],"balance_after":103973,"source":{"system":"sec-edgar","filing":"0001628280-25-026564","document":"wk-form4_1747688210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000162828025026564/wk-form4_1747688210.xml","form_type":"4"}},{"id":1469386,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-25T20:39:45.000Z","date":"2024-06-21","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units fully vested on June 21, 2024. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units fully vested on June 21, 2024. The restricted stock units have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001104659-24-074769","document":"tm2418139-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465924074769/tm2418139-5_4seq1.xml","form_type":"4"}},{"id":1469385,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-25T20:39:45.000Z","date":"2024-06-21","kind":"exercise","planned":false,"acquired":true,"shares":3000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001104659-24-074769","document":"tm2418139-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465924074769/tm2418139-5_4seq1.xml","form_type":"4"}},{"id":1472926,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-21T01:44:56.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."}],"balance_after":4000,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001104659-24-073637","document":"tm2417588-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465924073637/tm2417588-5_4seq1.xml","form_type":"4"}},{"id":1472925,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T01:44:56.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":14000,"derivative":{"exercise_price":41.39,"expiration_date":"2034-06-17","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001104659-24-073637","document":"tm2417588-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465924073637/tm2417588-5_4seq1.xml","form_type":"4"}},{"id":1483175,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T20:13:13.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) granted to the Reporting Person as an annual award for service on the Board of Directors. The RSUs will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders, subject to continued board service through the applicable vesting date. The RSUs will vest in full upon the occurrence of a change in control of the Issuer."}],"balance_after":96667,"source":{"system":"sec-edgar","filing":"0001628280-24-027676","document":"wk-form4_1718136785.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000162828024027676/wk-form4_1718136785.xml","form_type":"4"}},{"id":1516304,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-15T20:20:20.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":13162,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU was granted on May 13, 2024 for no consideration."}],"balance_after":98915,"source":{"system":"sec-edgar","filing":"0001628280-24-023568","document":"wk-form4_1715804396.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000162828024023568/wk-form4_1715804396.xml","form_type":"4"}},{"id":1845009,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-23T20:31:52.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units fully vest upon the earlier of (i) June 21, 2024 or (ii) the date of the Issuer's next annual meeting of the stockholders, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units fully vest upon the earlier of (i) June 21, 2024 or (ii) the date of the Issuer's next annual meeting of the stockholders, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."}],"balance_after":3000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001104659-23-074297","document":"tm2319485-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465923074297/tm2319485-6_4seq1.xml","form_type":"4"}},{"id":1845008,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T20:31:52.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest upon the earlier of (i) June 21, 2024 or (ii) the date of the Issuer's next annual meeting of the stockholders, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":14000,"derivative":{"exercise_price":18.47,"expiration_date":"2033-06-20","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001104659-23-074297","document":"tm2319485-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465923074297/tm2319485-6_4seq1.xml","form_type":"4"}},{"id":1855663,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-14T21:03:30.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (?RSUs?) granted to the Reporting Person as an annual award for service on the Board of Directors. The RSUs will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the Issuer?s next annual meeting of stockholders, subject to continued board service through the applicable vesting date. The RSUs will vest in full upon the occurrence of a change in control of the Issuer."}],"balance_after":51667,"source":{"system":"sec-edgar","filing":"0001628280-23-022093","document":"wk-form4_1686776597.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000162828023022093/wk-form4_1686776597.xml","form_type":"4"}},{"id":1893841,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-15T20:24:40.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":13192,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 11, 2023, for no consideration."}],"balance_after":85753,"source":{"system":"sec-edgar","filing":"0001628280-23-018207","document":"wf-form4_168418226315938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000162828023018207/wf-form4_168418226315938.xml","form_type":"4"}},{"id":2220974,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-27T20:10:44.000Z","date":"2022-06-06","kind":"grant","acquired":true,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") for service as a director to the Issuer. The RSUs will vest in two equal annual installments on June 6, 2023 and June 6, 2024, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents unvested RSUs."}],"balance_after":6667,"source":{"system":"sec-edgar","filing":"0001628280-22-018045","document":"wf-form4_165636062432823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000162828022018045/wf-form4_165636062432823.xml","form_type":"4"}},{"id":2235637,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T20:07:25.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest upon the earlier of (i) June 8, 2023 or (ii) the date of the Issuer's next annual meeting of the stockholders."}],"balance_after":20000,"derivative":{"exercise_price":4.15,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-22-070111","document":"tm2218129-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465922070111/tm2218129-5_4seq1.xml","form_type":"4"}},{"id":2272432,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-13T22:15:54.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":14645,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 11, 2022, for no consideration."}],"balance_after":72561,"source":{"system":"sec-edgar","filing":"0001140361-22-019179","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000114036122019179/form4.xml","form_type":"4"}},{"id":2671532,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T20:06:43.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest upon the earlier of (i) June 9, 2022 or (ii) the date of the Issuer's next annual meeting of the stockholders."}],"balance_after":15000,"derivative":{"exercise_price":18.99,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-21-080107","document":"tm2119501-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465921080107/tm2119501-5_4seq1.xml","form_type":"4"}},{"id":2686063,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-02T21:02:09.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":6000,"price":9.5,"value":57000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"8.3333% of the shares subject to the option shall vest on July 2, 2021, with the remainder vesting in equal monthly installments of 8.333% of the shares subject to the option until the 12-month anniversary of the date of the grant (or, if earlier, the date of the Issuer's next annual meeting of stockholders following the date of the grant) subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":6000,"derivative":{"exercise_price":9.5,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001628280-21-011542","document":"wf-form4_162266771107740.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000162828021011542/wf-form4_162266771107740.xml","form_type":"4"}},{"id":2712673,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-14T20:38:37.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":7558,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 12, 2021 for no consideration."}],"balance_after":57916,"source":{"system":"sec-edgar","filing":"0001140361-21-017425","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000114036121017425/form4.xml","form_type":"4"}},{"id":3105197,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-18T21:26:05.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest upon the earlier of (i) 1 year from the date of grant or (ii) the date of the Issuer's next annual meeting of the stockholders."}],"balance_after":18500,"derivative":{"exercise_price":21.37,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001104659-20-074730","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465920074730/a4.xml","form_type":"4"}},{"id":3113103,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-11T12:24:28.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":3427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"8.3333% of the shares subject to the option shall vest on July 10, 2020, with the remainder vesting in equal monthly installments of 8.333% of the shares subject to the option until the 12-month anniversary of the date of the grant (or, if earlier, the date of the Issuer's next annual meeting of stockholders following the date of the grant) subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":3427,"derivative":{"exercise_price":8.69,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":3427},"source":{"system":"sec-edgar","filing":"0001628280-20-009232","document":"wf-form4_159187825019179.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000162828020009232/wf-form4_159187825019179.xml","form_type":"4"}},{"id":3149270,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-15T01:00:01.000Z","date":"2020-05-12","kind":"grant","acquired":true,"shares":8097,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 12, 2020 for no consideration."}],"balance_after":50358,"source":{"system":"sec-edgar","filing":"0001104659-20-061857","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000110465920061857/a4.xml","form_type":"4"}},{"id":3443351,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-08-09T01:17:22.000Z","date":"2019-06-25","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will fully vest on the one year anniversary of the transaction date."}],"balance_after":65780,"derivative":{"exercise_price":6.02,"expiration_date":"2029-06-25","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000899243-19-021419","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000089924319021419/doc4a.xml","form_type":"4/A","original_submission_date":"2019-06-27"}},{"id":3476796,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-06-27T20:15:25.000Z","date":"2019-06-25","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will fully vest on the one year anniversary of the transaction date."}],"balance_after":65780,"derivative":{"exercise_price":6.02,"expiration_date":"2029-06-25","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000899243-19-018353","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000089924319018353/doc4.xml","form_type":"4"}},{"id":3481036,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-21T20:14:52.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest upon the earlier of (i) 1 year from the date of grant or (ii) the date of the Issuer's next annual meeting of the stockholders."}],"balance_after":15000,"derivative":{"exercise_price":22.93,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-19-037019","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465919037019/a4.xml","form_type":"4"}},{"id":3483880,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-19T20:18:28.000Z","date":"2019-06-17","kind":"grant","acquired":true,"shares":3427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"8.3333% of the shares subject to the option shall vest on July 17, 2019, with the remainder vesting in equal monthly installments of 8.3333% of the shares subject to the option until the 12-month anniversary of the date of the grant (or, if earlier, the date of the Issuer's next annual meeting of stockholders following the date of the grant), subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":3427,"derivative":{"exercise_price":14.75,"expiration_date":"2029-06-17","underlying":"Common Stock","underlying_shares":3427},"source":{"system":"sec-edgar","filing":"0000899243-19-017422","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000089924319017422/doc4.xml","form_type":"4"}},{"id":3524228,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-16T21:18:02.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":6899,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 15, 2019, and represents a contingent right to receive one share of Common Stock."}],"balance_after":42261,"source":{"system":"sec-edgar","filing":"0001127430-19-000078","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743019000078/edgar.xml","form_type":"4"}},{"id":3899694,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-08T20:04:16.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest upon the earlier of (i) 1 year from the date of grant or (ii) the date of the Issuer's next annual meeting of the stockholders."}],"balance_after":10000,"derivative":{"exercise_price":34.89,"expiration_date":"2028-06-05","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-18-039178","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000110465918039178/a4.xml","form_type":"4"}},{"id":3901351,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-07T20:22:03.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 1/12th of the shares underlying the award on the one-month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director through each applicable vesting date."}],"balance_after":10000,"derivative":{"exercise_price":16.99,"expiration_date":"2028-06-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-036342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000120919118036342/doc4.xml","form_type":"4"}},{"id":3928751,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-17T20:15:28.000Z","date":"2018-05-15","kind":"grant","acquired":true,"shares":6066,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 15, 2018, and represents a contingent right to receive one share of Common Stock."}],"balance_after":35362,"source":{"system":"sec-edgar","filing":"0001127430-18-000041","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743018000041/edgar.xml","form_type":"4"}},{"id":4014263,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-05T21:59:56.000Z","date":"2017-11-15","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of an automatic stock option grant that was made pursuant to the issuer's director compensation policy on November 15, 2017, the date of effectiveness of the registration statement for the issuer's initial public offering. Under the terms of the policy, the Reporting Person received an option to purchase 25,000 shares. Due to a clerical error, the original Form 4 filed on December 1, 2017 erroneously reported an option grant of 7,324 shares. This Amendment to Form 4 is filed solely to correct the share number."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as to 33.3333% of the shares underlying the award on the first anniversary of the date of grant, with the remainder vesting in equal monthly installments until the third anniversary of the date of grant, subject to the Reporting Person's continued service as a director through each applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":10,"expiration_date":"2027-11-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-18-016571","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000120919118016571/doc4a.xml","form_type":"4/A","original_submission_date":"2017-12-01"}},{"id":4145906,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-12-01T22:15:20.000Z","date":"2017-11-15","kind":"grant","acquired":true,"shares":7324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an automatic stock option grant that was made on November 15, 2017, the date of the effectiveness of the registration statement for the issuer's initial public offering, under the issuer's director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as to 33.3333% of the shares underlying the award on the first anniversary of the date of grant, with the remainder vesting in equal monthly installments until the third anniversary of the date of grant, subject to the Reporting Person's continued service as a director through each applicable vesting date."}],"balance_after":7324,"derivative":{"exercise_price":10,"expiration_date":"2027-11-14","underlying":"Common Stock","underlying_shares":7324},"source":{"system":"sec-edgar","filing":"0000899243-17-027819","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000089924317027819/doc4.xml","form_type":"4"}},{"id":4269043,"issuer":{"id":172682,"kind":"organization","name":"Roka BioScience, Inc.","symbol":"ROKA"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-30T13:27:22.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3000,"derivative":{"exercise_price":2.55,"exercise_date":"2018-06-28","expiration_date":"2027-06-27","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001472343-17-000043","document":"wf-form4_149882922876974.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219023/000147234317000043/wf-form4_149882922876974.xml","form_type":"4"}},{"id":4312023,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35343,"kind":"person","name":"MCGIRR DAVID W J","position":1,"cik":"0001219023","reported_name":"MCGIRR DAVID W J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-19T20:30:08.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":6702,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was received as a grant on May 17, 2017, and represents a contingent right to receive one share of Common Stock."}],"balance_after":29296,"source":{"system":"sec-edgar","filing":"0001127430-17-000044","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000044/edgar.xml","form_type":"4"}}]}